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An analytical procedure to quantify 3-benzophenone, octylmethoxycinnamate and octylsalicylate was validated and employed to 
assess these ultraviolet filters in sunscreen formulations and from skin penetration studies. The effect of the vehicle on the skin 
retention of these filters was investigated. HPLC and extraction procedure were found to be reliable when obtaining data for the 
sunscreen formulations and for evaluation skin penetration. The results demonstrated that a cream gel generated higher epidermal 
concentrations of these filters than a lotion or cream-based formulation. Additionally, when comparing the skin retentions of each 
filter using the same formulation, 3-benzophenone showed the highest skin retention.
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INTRODUCTION
Oxidative stress and inflammatory responses induced by ultra-
violet (UV) radiation can cause a variety of harmful effects in skin, 
including premature photoaging and the induction of immunosup-
pression and skin carcinogenesis.1-3
To limit sun exposure, the government advises one to wear loose 
fitting, tightly woven clothing, to stay in the shade between 11 a.m. 
and 3 p.m. and to use a sunscreen with a sun protection factor (SPF) 
of 15 or higher liberally reapplying every 2 h or after working, swim-
ming, playing or exercising outdoors.4,5 
The necessity to provide high SPF and screening efficiency 
against both ultraviolet A (UVA) and ultraviolet B (UVB) wavelengths 
has led to the development of sunscreen formulations with multiple 
added sunscreen chemicals.6
Of the approved sunscreen chemicals, 3-benzophenone (3-BZ), 
octylmethoxycycinnamate (OMC), and octylsalicylate (OS) are some 
of the most common active ingredients used in sunscreen formula-
tions.7 Benzophenones efficiently absorb both UVA and UVB rays, 
and 3-BZ is the most commonly used in sunscreen formulations. 
Among the cinnamates, OMC is the most widely used UVB filter in 
the world. It is often used in combination with other filters to achie-
ve a high SPF in the final product. Salicylates, such as OS, absorb 
UVB radiation, are very stable, and are insoluble in water. They are 
commonly used to improve the substantivity of the formulation and 
reduce the photodegradation of some sunscreens.8
When formulating sunscreens, the sunscreen agents should re-
main on the surface of the skin, accumulate in the stratum corneum, 
and create a barrier against UV radiation without transdermally 
penetrating systemic circulation.9 Unfortunately, several studies 
have demonstrated that some UV filters, such as 3-BZ, OMC, and 
OS, can penetrate the epidermis.7,10-13 Additionally, recent reports 
have shown that when the filters, 3-BZ, OMC and octocrylene, 
penetrate into these nucleated layers, the levels of reactive oxygen 
species produced naturally by the epidermal chromophores under 
UV illumination increase.14
It is important to consider that sunscreen formulations are applied 
to a large area of the body and for long periods of time, producing a 
constant and high input of the chemical into the viable skin layer and 
into systemic circulation.3 The development of formulations and the 
synthesis of new sunscreen molecules with good substantivity have 
been of great interest to decrease absorption and to improve the safety 
and effectiveness of the topical sunscreen formulations.15-17
In this context, it is of great importance to develop adequate, relia-
ble and sensitive new techniques to extract and quantify the sunscreens 
in the formulations and from the skin samples. These techniques can 
then aid in the safety of sunscreen formulations because studies have 
also demonstrated that UV filters can be found in the deeper layers of 
the skin, in urine, in plasma, and even in breastmilk.7,10-13,18
First in this study, a reverse phase-high-performance liquid chro-
matography (RP-HPLC) technique and an extraction procedure for 
simultaneous determination of the three UV filters in the sunscreen 
formulations, and from skin samples were developed and validated. 
Second, the applicability of this method for determining skin penetra-
tion was investigated. Last, the effects of the three different sunscreen 
formulations were investigated by testing the skin penetration of 
3-BZ, OMC, and OS in vitro.
EXPERIMENTAL
Reagents
3-benzophenone (99.9%, Eusolex® 4360), octylmethoxycinnamate 
(99.9%, Eusolex® 2292), and octylsalicylate (99.8%, Eusolex® OS) were 
purchased from Merck (Darmstadt, Germany). Acetic acid (chromatogra-
phic grade) was supplied by Merck (Darmstadt, Germany) and methyl 
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alcohol (MeOH) for use in the chromatograph was purchased from J. T. 
Baker (USA). The water used to prepare the solutions and the mobile 
phase was purified by a Milli-Q-plus System (Millipore®, Bedford, MA, 
USA). Ethyl alcohol was supplied from Synth (Sao Paulo, Brazil). All of 
the raw materials used for the formulations were purchased from Galena 
(Campinas, SP, Brazil) or Clariant (Sao Paulo, SP, Brazil). All other che-
micals were of reagent grade and were used without further purification.
Sunscreen formulations
The study was performed using 3 model formulations of suns-
creen: cream, lotion and cream gel, each containing a mixture of the 
3 organic UV filters. 
3-BZ (4.0%, w/w), OMC (7.5%, w/w), and OS (5.0%, w/w) were 
incorporated into the formulations at room temperature 24 h after their 
preparation, and the pH was adjusted to 6.0 using aminomethylpro-
panol. 3-BZ was first solubilized in propylene glycol and was then 
incorporated into the formulations. Blank formulations were prepared 
containing all of the components without the UV filters. The percent 
composition of each formulation is described in Table 1. 
Determination of 3-benzophenone, octylmethoxycinnamate 
and octylsalicylate by HPLC
Chromatographic conditions
The presence of the UV filters 3-BZ, OMC, and OS, was de-
termined using a Shimadzu (Kyoto, Japan) liquid chromatograph 
system equipped with an LC-10 AT VP solvent pump unit and an 
SPD-10A VP UV-Visible detector operating at 305 nm. Separation 
was performed on a SupelcosilTM LC-18 (25 cm x 4.6 mm, 5 µm) 
column equipped with a C-18 (4 x 4 mm, 5 µm, Merck) precolumn. 
This procedure was adapted from previously described techniques.19,20
The mobile phase was a MeOH/water (84:16, v/v) mixture 
containing 0.1% (v/v) acetic acid. The flow rate was 1 mLmin-1, 
and the system was run at room temperature. Data were collected 
using a Chromatopac C-R6A integrator (Shimadzu, Kyoto, Japan). 
All solutions and solvents were filtered through a Millipore® filter 
membrane (pore size = 0.45 µm) and were vacuum degassed by 
sonication before use.
Standard solution
Standard solutions of the UV filters were prepared daily. The 
individual solutions of all of the UV filters were prepared by dis-
solving 0.025 g of samples in 25 mL of mobile phase followed by 
ultrasonication at room temperature for 15 min. This solution was 
further diluted (10x) in a mobile phase. Standard solutions with con-
centrations of at 4 mg/mL for 3-BZ, 7.5 mg/mL for OMC, and 5 mg/
mL for OS were prepared. All samples were quantified by comparing 
the peak areas of the samples with the peak areas of the reference 
substances present in the standard solution.
Method validation
Validation was performed following the ICH guidelines.21 The 
method was validated considering the parameters of linearity, accu-
racy, precision, specificity and the limits of detection and quantitation.
Linearity was tested using the standard solutions of 3-BZ, 
OMC, and OS. Calibration curves were prepared using 5 different 
concentrations of each of the UV filters (2.5-15.0 mg/mL) and were 
analyzed by the linear regression of the peak areas versus the UV 
filter concentrations. 
Precision was expressed as a relative standard deviation (RSD%) 
and was determined by repeatability (intra-day) and intermediate 
precision (inter-day). Repeatability was evaluated by the analysis 
of six replicates of each experiment during the same day and under 
the same experimental conditions. The intermediate precision was 
tested by assaying six replicates on three different days. The concen-
trations used were 4.0 mg/mL for 3-BZ, 7.5 mg/mL for OMC, and 
5.0 mg/mL for OS.   
Accuracy was determined based on recovery tests performed 
by adding known amounts of the UV filters to blank formulations. 
Samples of 0.05 g of the formulations containing all three UV filters 
were dissolved into 50 mL of ethanol. For the preparation of samples 
of the low, medium and high concentration, 0.8, 1.0, and 1.2 mL, 
respectively, of these solutions were diluted with mobile phase in 
a 10-mL volumetric flask. Each of the solutions were filtered and 
injected into the HPLC system. Accuracy was expressed as a percent 
of recovery, which was estimated from the relationship between the 
experimental and theoretical concentrations ((Ce/Ct) x 100).
The detection limit (LD) and quantitation limit (LQ) were determi-
ned from the standard deviation of the response and from the slope of 
the constructed calibration curve. The LD was expressed as (3.3 x ơ)/S 
and, the LQ was expressed as (10 x ơ)/S, where ơ is the standard 
deviation of the response and S is the slope of calibration curve.
The specificity was determined by comparing the results obtained 
by the analyses of the standard solution, of the blank formulation and 
of the formulations containing the three UV filters.
Applicability of the technique
In this study, the applicability of the HPLC technique for the 
analysis of the in vitro retention studies of the topical formulations 
spiked with 3-BZ, OMC, and OS was investigated by treating the pig 
ear skin sections (area of 1.77 cm2) with methanolic solutions of the 
UV filters, prepared as described below. These methanolic solutions 
consisted of 0.5, 0.1 or 0.02% of the UV filters contained in 300 mg 
of the formulation in every 100 µL of sample. The treated skin sec-
tions were allowed to rest for 30 min before they were submitted to 
the extraction process (procedure described below). The UV filters 
extracted from these skin sections were quantified by HPLC, and the 
pig skin sections without addition of any solution were also analyzed. 
In vitro skin penetration
To conduct this study the skin from the outer surface of an exci-
sed porcine ear was used. Pig ears were obtained within 2 h after the 
Table 1. Percent composition (w/w) of the formulations 
Component Cream Lotion Cream gel
Polawax® a  3.0 1.0 1.5
Carbopol® 940 b - - 0.5
Cetyl alcohol 3.5 1.5 1.75
Stearic acid 4.0 1.5 2.0
Gliceryl monostearate 5.5 3.5 2.75
Propylparaben 0.05 0.025 0.025
Methylparaben 0.05 0.025 0.175
EDTA 0.15 0.15 0.075
Propylene glycol 15.0 10.0 10.0
Distilled water 68.75 82.3 81.23
aSelf-emulsifying wax (cetostearyl alcohol and polyoxyethylene derived 
from fatty acid ester sorbitan 2OE). bAnionic hydrophilic colloid (carboxy-
polymethylene).
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slaughter of the animals. The whole skin membrane was carefully 
removed from the underlying cartilage with a scalpel. Additionally, 
the subcutaneous tissues were removed, and the skin was stored at 
-20 °C for a maximum period of 30 d before use.22,23
A Franz diffusion cell (diffusion areas of 1.77 cm2) was used 
to perform the study, with the stratum corneum facing the donor 
compartment (where the formulation was applied) and the dermis 
facing the receptor compartment. The receptor chamber contained 150 
mM of phosphate buffer (pH 7.2) in polyoxyethylene (20) sorbitan 
monolaurate (Tween 20®) (0.5%, v/v), and the fluid was mantained 
under constant stirring and temperature (37 ± 0.5 oC).24
The formulations cream, lotion, and cream gel, containing a UV 
filters and unloaded formulations (300 mg of each) were applied to the 
surface of the stratum corneum, while avoiding light exposure. Six hours 
post-application of the formulations, the skin surfaces were wiped with a 
cotton swab to remove any excess formulation. To separate the stratum 
corneum from the remaining epidermis and dermis, the skin sections were 
subjected to tape stripping with 15 pieces of adhesive tape.
The remaining epidermis and dermis were cut in small pieces, 
bath sonicated for 30 min in 2.5 mL of MeOH, vortex mixed for 1 
min and centrifuged for 15 min at 15000 rpm. The supernatant was 
transferred to a 5 mL volumetric flask. To the remaining precipitate, 
2.5 mL of methanol was added, and the extraction procedure was 
repeated. The supernatant of the second extraction was added to 
the previous sample in the volumetric flask, and these samples were 
diluted with methanol to fill the flask. The resulting mixture was 
filtered using a 0.45-µm membrane, and the sunscreens were assayed 
by HPLC, as described previously. 
Statistical analysis
Data were statistically analyzed by one-way ANOVA, followed 
by Bonferroni’s multiple comparison t-tests. The level of significance 
was set to a p-value < 0.05.
RESULTS 
Determination of 3-benzophenone, octylmethoxycinnamate 
and octylsalicylate by HPLC
The chromatographic analysis for the quantitative determination 
of the UV filters was validated according to ICH guidelines21 to obtain 
reproducible analyses with high accuracy and precision in the range 
of the concentrations investigated.
The proposed HPLC technique enabled the separation and quan-
titative determination of the three UV filters present in the sunscreen 
formulations and from the porcine skin samples. Isocratic elution with 
MeOH/water (84:16, v/v) containing 0.1% (v/v) acetic acid was found 
to be simple in comparison to other studies that used gradient elution 
techniques.7 As demonstrated in Figure 1, 3-BZ, OMC, and OS had 
reten tion times of approximately 6, 17, and 19 min, respectively, 
allowing for the rapid determination of these UV filters, which is 
essential for routine analysis. 
Furthermore, the specificity study showed that the blank formula-
tions did not display interference with regard to the chromatographic 
characteristics. Additionally, in the presence of the different formula-
tion components, the chromatographic profiles of 3-BZ, OMC, and 
OS (retention times and areas) were not affected (data not shown).
The calibration curves were linear within the concentration range 
of 2.5-15 µg/mL for each of the UV filters, and the regression analyses 
gave the following representative linear equations: y = 41490x - 13080 
for 3-BZ, y = 60800x + 11150 for OMC, and y = 15350x - 3130 for 
OS. The correlation coefficients (r) were all above 0.999.
The detection limits of 3-BZ, OMC, and OS were 0.36, 0.38, and 
0.27 µg/mL, respectively, and the quantitation limits were 1.12, 1.15, 
and 0.81 µg/mL, respectively.
The precision of the method was determined by repeatability 
(intra-assay) and intermediate precision (inter-assay), and is shown 
as the relative standard deviation (R.S.D%). The repeatability and 
intermediate precision for the three sunscreens were all less than 
5% which can be considered satisfactory for the purpose of this 
analysis (Table 2).
The accuracy for the detection of the UV filters in the formula-
tions varied from 88.3-101.1% for the cream, 87.1-106.2% for the 
lotion, and 87.3-100.1% for the cream gel (Table 3). These results 
can be accepted due to the complexity of the cosmetic formulation 
determination.25
Applicability of the technique
The recoveries of 3-BZ, OMC, and OS from the skin samples 
were all above 70% (Table 4). Therefore, the combined proce-
dures for the extraction and HPLC assaying of these sunscreen 
agents in the skin samples are efficient in terms of recovery and 
fast manipulation.
In vitro skin penetration
As demonstrated by Figure 2 and Table 5, 3-BZ, OMC, and OS 
showed a potential for skin penetration in the cream, lotion, and 
cream gel formulations.
Figure 1. Chromatogram of the standard solution for (A) 3-benzophenone 
(4.0 µg/mL), (B) octylmethoxycinnamate (7.5 µg/mL), and (C) octylsa-
licylate (5.0 µg/mL)
Table 2. Precision of the HPLC technique for the quantification of the UV 
filters in the sunscreen formulations
Cream gel Cream Lotion
Inter-day variationa RSD (%) RSD (%) RSD%
3-BZ (4 µg/mL) 2.92 3.15 4.23
OMC (7.5 µg/mL) 3.53 2.39 3.51
OS (5 µg/mL) 3.03 2.16 3.28
Intra-day variationb
3-BZ (4 µg/mL) 2.44 2.55 2.31
OMC (7.5 µg/mL) 1.88 2.31 2.61
OS (5 µg/mL) 2.47 1.69 2.66
The results are presented as the mean ± the standard deviation (SD). aSix 
replicates were assayed on three different days. bSix replicates were assayed 
on the same day.
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The cream gel formulation provided the highest retention of the 
sunscreens in the epidermis and dermis, while the skin retentions 
of the cream and lotion emulsions were not significantly different. 
The skin retention of 3-BZ in the cream gel was 1.9- and 1.8-fold 
higher than in the cream and lotion, respectively. The skin retention 
of OMC when the carrier was a cream gel was 2.86 and 3.66 higher 
than when the cream and lotion, respectively, were used. Finally, the 
skin retention of OS in the cream gel was 2.53 and 3.22 higher than 
in the cream and lotion formulations, respectively.
DISCUSSION
Considering the great necessity for the development of ade-
quate, reliable and sensitive techniques to extract and quantify the 
sunscreens in the formulations and from the skin samples as well 
as to ensure the safety of the sunscreen formulations, the present 
study aimed to develop and validate a RP-HPLC technique for 
the analysis of three UV filters found in sunscreen formulations 
and skin samples. In addition, the in vitro skin penetration effects 
of three different sunscreen formulations containing UV filters 
were investigated.
The values obtained for linearity, precision, accuracy, detection 
limit and quantitation limit were in accordance with the ICH gui-
delines,21 which indicate that the chromatographic conditions used 
are reliable to quantify 3-BZ, OMC, and OS in the range evaluated. 
Moreover, no interference from the formulations and the extracted 
skin endogenous compounds were observed, indicating the applicabi-
lity of this technique with the in vitro retention studies of the topical 
formulations containing the UV filters.
Considering the significant difference between the retention va-
lues of the sunscreen incorporated into the cream gel in comparison 
with the other formulations, it might be suggested that the affinities 
of the sunscreens to the vehicles differed. The cream and lotion 
formulations have higher oil contents than the cream gel; therefore, 
the UV filters, which have high lipophilic characteristics, most likely 
remain in the cream and lotion formulations. Thus, the UV filter in 
these formulations would not as readily penetrate the skin. 
Studies have shown that emulsion-gel provides greater retention 
of 3-BZ, OMC, and OS in the epidermis compared to the petroleum 
jelly.13 Additionally, the penetrations and stratum corneum retentions 
of the UV filters are formulation dependent.10 Therefore, corrobo-
rating with Treffel and Gabard13 and Gupta et al.,10 the formulation-
dependent skin penetrations of the investigated UV filters were 
detected in the present study. Also for these reasons, the vehicle should 
be carefully chosen to prevent the skin penetration of the cosmetic 
formulations containing the sunscreen agents.
In comparing the skin retentions of each UV filter in the same 
formulation, expressed as percentages of the applied doses, 3-BZ 
showed higher skin retention than the other two filters. This di-
fference in the 3-BZ retention, when compared to those of OMC 
Table 3. Accuracy of the HPLC technique for the quantification of the UV filters in the sunscreen formulations
Cream gel Cream Lotion
Theoretical concen-
tration (µg/mL)
Experimental concen-
tration (µg/mL)
Recovery 
(%)
Experimental concen-
tration (µg/mL)
Recovery 
(%)
Experimental concen-
tration (µg/mL)
Recovery 
(%)
3-BZ
3.2 3.03 ± 0.11 94.05 3.09 ± 0.03 95.37  3.06 ± 0.01 94.43 
4.0 3.79 ± 0.01 94.13 3.94 ± 0.03 97.17 3.75 ± 0.03 92.55 
4.8 4.51 ± 0.05 93.44 4.73 ± 0.06 97.18 4.53 ± 0.04 93.37 
OMC
6.0 6.04 ± 0.21 100.11 6.11 ± 0.11 100.33 6.46 ± 0.09 106.23 
7.6 7.48 ± 0.08 99.16 7.66 ± 0.02 100.66 7.81 ± 0.05 102.75 
9.1 8.86 ± 0.04 99.00 9.23 ± 0.20 101.06 9.44 ± 0.11 103.43 
OS
4.1 3.82 ± 0.15 92.84 3.64 ± 0.04 88.29 3.62 ± 0.01 87.93 
5.1 4.52 ± 0.01 87.89 4.64 ± 0.04 90.07 4.45 ± 0.01 87.14 
6.1 5.39 ± 0.06 87.26 5.59 ± 0.07 90.4 5.39 ± 0.05 87.93 
The results are the mean ± SD of three experiments.
Table 4. Recoveries of 3-benzophenone, octylmethoxycinnamate, and 
octylsalicylate extracted from the viable epidermis and dermis
Theoretical 
concentration (µg)a
Experimental 
concentration (µg)
Recovery 
(%)
3-BZ 2.4 1.76 ± 0.03 73.32
12.0 9.51 ± 0.39 79.19
60.0 44.26 ± 2.00 73.72
OMC 4.5 4.08 ± 0.11 90.68
22.5 19.60 ± 0.66 87.03
112.5 111.82 ± 5.82 99.33
OS 3.0 2.95 ± 0.24 98.41
15.0 11.22 ± 0.55 74.77
75.0 53.15 ± 1.62 70.81 
a3-BZ, OMC, and OS, each in a 100 µL methanolic solution added to the skin 
samples. The results are the mean ± SD of three experiments.
Figure 2. HPLC chromatograms of the skin retentions for the three sunscreen 
formulations cream gel (A), cream (B), and lotion (C) containing the UV filters
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Table 5. Amount of UV filters retained in the epidermis and dermis for the three formulations after 6 
Cream gel Cream Lotion
Retentiona Retentionb Retentiona Retentionb Retentiona Retentionb
3-BZ 27.75 ± 5.97* 0.41 ± 0.09* 14.84 ± 1.76 0.22 ± 0.03 15.83 ± 1.73 0.23 ± 0.02
OMC 32.70 ± 9.91* 0.26 ± 0.07* 11.40 ± 3.36 0.09 ± 0.02 8.93 ± 3.96 0.07 ± 0.03
OS 18.33 ± 5.85* 0.22 ± 0.06* 7.24 ± 1.86 0.08 ± 0.02 5.70 ± 1.95 0.07 ± 0.02
aThe UV filter retentions are expressed as µg/cm2. bThe UV filter retentions are expressed as percentages of the applied doses. Results are represented as means 
± SD (n =6). Statistical analysis was performed by a one-way ANOVA followed by a Bonferroni’s test of the multiple comparisons. *Significant statistical 
difference compared to the cream and lotion formulations (p < 0.05).
and OS, was approximately 1.7-, 2.6-, and 3.3-fold higher in the 
cream gel, cream, and lotion formulations, respectively. These 
results may be attributed to the different physical characteristics 
and chemical properties of each UV filter; these properties affect 
the penetrability of the compounds into the stratum corneum and 
into the deeper layers of skin.
3-BZ is characterized by a relatively low molecular weight 
(228.25) and a log P of 3.5813 which suggest that 3-BZ has a good 
ability to penetrate the skin.26 Comparatively, the oil-water partition 
coefficients (octanol/water partition) for OMC and OS are 5.96 and 
6.02, respectively, indicating they are both highly lipophilic. Due to 
these high lipophilicities, it is likely that the compounds are capable 
of accumulating and forming reservoirs within the lipid phases of the 
stratum corneum. Additionally, these agents would have difficulty 
penetrating the viable epidermis because of the hydrophilic nature of 
this layer.27 In other words, these characteristics explain the superior 
penetrating capability of 3-BZ into the skin when compared to OMC 
and OS. Furthermore, Gupta et al.10 showed that 3-BZ presented a 
higher penetration into the viable epidermis and dermis, whereas the 
OMC showed better retention in the stratum corneum.
CONCLUSION
The results demonstrate that the proposed chromatographic 
technique is a useful and reliable tool for the analysis of sunscreens 
in formulations and from skin samples. It not only provided the de-
tection and quantification of the microquantities in the samples, but 
it also eliminated most of the interference problems caused by the 
formulations and the skin in the samples. In other words, this tech-
nique should enable the development of studies and quality controls 
of the sunscreen formulations.
Furthermore, cream gel formulation generated the highest epi-
dermal concentration of the studied UV filters, and by comparing the 
skin retention amounts of each sunscreen in the same formulation, 
3-BZ showed the highest skin retention ability. Therefore, formula-
tions must be developed to minimize the penetration of these UV 
filters into the deeper layers of skin, and they must take into account 
the physical and chemical properties of the sunscreen formulation 
components and of the UV filters. Additionally, it is indispensable 
that penetration studies of the sunscreens into the skin be developed 
to ensure the safety of the sunscreen formulations.
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